| Literature DB >> 21331185 |
S Jeevanandham1, M Sekar, D Dhachinamoorthi, M Muthukumaran, N Sriram, J Joysaruby.
Abstract
This study examines the sustaineEntities:
Keywords: Kernel powder; Leucaena leucocephala; mucoadhesives
Year: 2010 PMID: 21331185 PMCID: PMC3035878 DOI: 10.4103/0975-1483.62207
Source DB: PubMed Journal: J Young Pharm ISSN: 0975-1483
Formulations of various Leucaena leucocephala seed polysaccharide matrices
| Ingredients | Drug type (mg/tablet) | Cross linker (mg/tablet) | Diluents (mg/tablet) |
|---|---|---|---|
| Drug Substance | 50 | 50/100 | 50 |
| LLSP | 200 | 0 | 180/160/140/120/100/80 |
| Cross-linked LLSP | 0 | 200 | 0 |
| Lactose/MC | 0 | 0 | 20/40/60/80/100/120 |
| Magnesium Stearate | 2.5 | 2.5/3 | 2.5 |
Caffeine/acetaminophen/theophylline/salicylic acid/indomethacin
Leucaena Leucocephala seed polysaccharide
Microcrystalline cellulose
List of model drugs used for preparation of matrix tablet
| Drug type | Solubility in water at 37°C (mg/ml) | Detection wavelength (nm) |
|---|---|---|
| Caffeine anhydrous | 37.0 | 273 |
| Acetaminophen | 18.9 | 242 |
| Theophylline anhydrous | 9.9 | 271 |
| Salicylic acid | 3.1 | 297 |
| Indomethacin | 0.9 | 318 |
Prepared in phosphate buffer - pH -7
Variation of n values with the mechanism of diffusion
| Mechanism | dM | |
|---|---|---|
| 0.5 | Fickian diffusion | |
| 0.5 < | Anomalous diffusion | |
| 1.0 | Case II transport | Zero order |
| Super case II transport |
Figure 113C-N.M.R. spectrum of leucaena leucocephala seed polysaccharide
Figure 2X-ray diffraction pattern of leucaena leucocephala seed polysaccharide
Figure 3Release profile of drugs of different solubility from leucaena leucocephala seed polysaccharide tablets (mean ± SD; n = 3)
The n value of the formulations containing drug type with D:P ratio of 1:4 and cross linker with D:P ratio of 1:2 and 1:4
| Formulation | |
|---|---|
| Drug type | |
| Caffeine | 0.60 |
| Acetaminophen | 0.66 |
| Theophylline | 0.71 |
| Salicylic acid | 0.73 |
| Indomethacin | 0.98 |
| Cross-linker | |
| 1:2 | 1.24 |
| 1:4 | 1.25 |
Figure 4Effect of replacing leucaena leucocephala seed polysaccharide with lactose on release of caffeine (mean ± SD; n = 3)
Figure 5Effect of replacing leucaena leucocephala seed polysaccharide with microcrystalline cellulose on release of caffeine (mean ± SD; n = 3)
The n value of formulations containing D:P ratio of 1:4 when replacing the polymer with different amount of lactose and microcrystalline cellulose
| Replacement | t50 | |
|---|---|---|
| Lactose (%) | ||
| 0 | 0.60 | 50.0 |
| 10 | 0.59 | 4.5 |
| 20 | 0.60 | 4.0 |
| 30 | 0.61 | 3.75 |
| 40 | 0.61 | 3.5 |
| 50 | 0.61 | 2.5 |
| 60 | 0.59 | 2.0 |
| MC (%) | ||
| 0 | 0.60 | 5.0 |
| 10 | 0.59 | 4.5 |
| 20 | 0.56 | 4.5 |
| 30 | 0.56 | 4.0 |
| 40 | 0.58 | 3.5 |
| 50 | 0.57 | 3.15 |
| 60 | 0.52 | 2.5 |
Figure 6Release profile of acetaminophen from cross-linked leucaena leucocephala seed polysaccharide tablets (mean ± SD; n = 3)